TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Bone densitometry results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of group B streptococcal (GBS) disease
Endpoint domain: Mortality/survival
Primary endpoint: Case Fatality Rate of GBS disease
Endpoint domain: Mortality/survival
Primary endpoint: GBS serotype distribution
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Behavioral test main outcome measures
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Brain MRI scan measures
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Transcranial magnetic stimulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: PI-2620 uptake measured by standard uptake value ratio (SUVR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Glasgow Coma Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Experiences of living with Chronic Kidney Disease
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Experiences of exercise and physical activity
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Systemic reactions other than fever
Endpoint domain: Adverse events/effects
Primary endpoint: Changes in mean blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Rate of tumor growth
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Reduction in respiratory severity score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in mean daily physical activity
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: VAS for back pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Model for End Stage Liver Disease (MELD) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in formation of atelectasis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Steady state glucose infusion rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Feasibility of system wide adoptability
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Replicability to other health systems
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Survival to cardiac transplantation or survival and transplant listed at 180 days
Endpoint domain: Mortality/survival
Primary endpoint: Number and severity of hot flashes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lower Limb Volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants Who Achieved a ≥ 1-Stage Improvement in Fibrosis Without Worsening of NASH at Week 48
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Serum Creatine kinase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of patients progressing from GOLD 0 stage to GOLD I stage or higher
Endpoint domain: Mortality/survival
Primary endpoint: Satisfaction of care
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Type of haptoglobin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: P2Y12 Reaction Units (PRU) at 0.5 Hours After Loading Dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: P2Y12 Reaction Units (PRU) at 1 Hour After Loading Dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Lateral Humerocapitellar Angle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Return-of-spontaneous-circulation (ROSC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Anatomic repair of the rotator cuff
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: serum total IgE level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Half-life of Ranibizumab
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Half-life of Aflibercept
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Heart Failure Hospitalizations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Improvement in 6 MWT Distance (in Meters)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: KCCQ (Number of Points Improved)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Number of Participants Responding as Per Physician's Global Assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Abnormal interpretation rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Obsessive-compulsive severity change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: APC resistance (factor V mutation)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Centrally Assessed Progression Free Survival
Endpoint domain: Mortality/survival
Primary endpoint: CD4+ T Cell Responses Detected in the Peripheral Blood or Vaccine-draining Lymph Node
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Serum estrone sulphate levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: GSRS-IBS score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: IBS-IS score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Increase in Infection or Serious Adverse Events (SAEs) Related to Single Dose Administration of Ustekinumab
Endpoint domain: Adverse events/effects
Primary endpoint: Increase in Infection or Serious Adverse Events (SAEs) Related to Multi-dose Administration of Ustekinumab (Cohort 1)
Endpoint domain: Adverse events/effects
Primary endpoint: Increase in Infection or Serious Adverse Events (SAEs) Related to Multi-dose Administration of Ustekinumab (Cohort 2)
Endpoint domain: Adverse events/effects
Primary endpoint: mVO2 recovery time constant (k)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants Eradicated of S. Aureus Carriage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Normal physiological level of Vitamin D3
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Wrinkle Severity Rating Scale score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Aesthetic Numeric Scale
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Fruit and vegetable acceptance
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Relative fruit and vegetable acceptance
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Chronic pain
Endpoint domain: Life impact
Endpoint subdomain: Pain
Primary endpoint: Levels of oral Streptococcus mutans
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hostile Attribution Bias
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Driving Aggression
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Aggression On Social Media
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Asthma Control Test (ACT) Score Change
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Safety assessed by grade 2 or higher adverse event
Endpoint domain: Adverse events/effects
Primary endpoint: Increase in healthy new nail growth free of fungal infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Number of participants with unhealed extraction socket
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Change in menstrual pain level assessed via 11-point numeric rating scale (NRS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinically Useful Depression Outcome Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Number of Patients Who Experienced Serious and Non-serious Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: ST interval and repolarization measures
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Serum ALP Level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent change of LDL-C level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Plasma and leukocyte vitamin C concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Rate of any stroke
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of Subjects With HPV DNA in Cervical Samples by Hybrid Capture 2 Test (HCII)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Subjects With Cytological Abnormalities in Cervical Samples by ThinPrep PapTest
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Subjects With Adverse Events (AEs) or Serious Adverse Events (SAEs) Leading to Withdrawal
Endpoint domain: Adverse events/effects
Primary endpoint: Change in blood flow at 10 min
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change in blood flow at 60 min
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: HIV drug resistance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Induction of inflammatory and/or apoptotic response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change from baseline frequency of gags
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline latency to clean mouth
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline frequency of emesis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Operative Mortality (OM)
Endpoint domain: Mortality/survival
Primary endpoint: Rate of permanent Neurologic Deficit (PND)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Rate of perioperative Myocardial Infarction (MI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: postoperative short-term outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Subjective pain scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adherence to physical activity guidelines
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Total fasting cholesterol
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Missed doses of VTE prophylaxis
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants With Treatment-Associated Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants Discontinuing Subsequent to Defined Intolerance
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Binge Drinking Days During Treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Locoregional Control (LRC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Amount of Opioid type pain medication used
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Parent Proxy-Reported Health-related Quality of Life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Percentage Change From the Baseline in S6 Kinase Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change in WOMAC Pain subscale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: patient global assessment of response to therapy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: change in WOMAC function subscale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative SIRS
Endpoint domain: Adverse events/effects
Primary endpoint: Improved Eckardt Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain intensity measured by algometry
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain intensity measured by visual analogue scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient reported outcome measures
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Incidence of postpericardiotomy syndrome
Endpoint domain: Adverse events/effects
Primary endpoint: Freedom From Major Adverse Device Effects
Endpoint domain: Adverse events/effects
Primary endpoint: Distribution of Major Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Change in child BMI z-score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Shared Decision Making Conversations
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Treatment Satisfaction and Acceptability
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Prevalence of aortic stenosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Detection rate of aortic stenosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Body Fat mass
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of participants with HIV-1 RNA < 50 copies/mL
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Subjective wakefulness levels
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Prednisolon levels in blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change From Baseline in Glucose Disposal Rate: Insulin Ratio During Steady State (M/I)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change From Baseline in Endogenous Glucose Production (EGP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change From Baseline in Rate of Glucose Disappearance (Rd)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Improvement in Non-alcoholic Fatty Liver Disease (NAFLD) Activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Occupational Performance History Interview-II (OPHI-II) Total and Subscale Scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Amount of Blood Vessel Tortuosity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Urine screen results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Startle reflex response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vitamin D level (status)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Total area under the plasma drug concentration-time curve (AUC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Apparent terminal half-life of the analyte in plasma (t1/2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pharmacokinetic-area under plasma concentration versus time curve
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Corneal Staining Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With Objective Response Per RECIST 1.1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Number of Participants With Treatment Related Dose Delay or Treatment Discontinuation
Endpoint domain: Adverse events/effects
Primary endpoint: Change From Baseline in Clinical Global Impression-Severity (CGI-S) Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of surgeries
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Mean Wavefront aberrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Knowledge Test Scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Weight gain pattern
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Percentage of Patients to Experience Any Treatment-emergent Adverse Event
Endpoint domain: Adverse events/effects
Primary endpoint: Investigator Global Assessment (IGA) Score of 1 or 0
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peak Itch Intensity During Non-histaminergic Itch Induction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Peak Itch Intensity During Histaminergic Itch Induction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Deep Vein Thrombosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Pulmonary Embolism
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Length of Time Typing QWERTY Prior to Experiencing Symptoms of CTS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Length of Time Typing FingerRelief Prior to Experiencing Symptoms of CTS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Biomarkers of liver fibrosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: TB incidence after injection of Vaccae
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Incidence of musculoskeletal health functioning problems
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Incidence of >= Grade 3 Mucositis
Endpoint domain: Adverse events/effects
Primary endpoint: 4-month Progression-free Survival
Endpoint domain: Mortality/survival
Primary endpoint: Ability to consent
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Infection of Surgical Site (SSI)
Endpoint domain: Adverse events/effects
Primary endpoint: Fractional catabolic and production rates of LDL-apoB and HDL-apoA-I
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in Range of movement in Upper Cervical Spine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Number of patients with at least one preventable medication error
Endpoint domain: Adverse events/effects
Primary endpoint: Gadolinium deposition in bone
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gadolinium deposition in skin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Duration of Radiation Induced Severe Oral Mucositis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Adverse events (AE) experienced with the RC+S system
Endpoint domain: Adverse events/effects
Primary endpoint: Number of subjects with related adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants With an Investigator's Assessment of Clinical Outcome (Effective (Cured)/ Not Effective (Not Cured))
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With Treatment Related Adverse Events (TRAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Unlisted Treatment Related Adverse Events (TRAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of active, collaborative and passive patients
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Proportion of patients who chose an oncological regimen more intense than recommended
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Proportion of patients choosing radical mastectomy over lumpectomy
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: All cause severe dengue
Endpoint domain: Mortality/survival
Primary endpoint: Patient expression of emotion
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Serum levels of TRAP-5b
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 30 Minute Pain Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: clinical courses
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ADA concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Influenza vaccine uptake
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Peak plasma cortisol concentration (Cmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Time of peak plasma cortisol concentration (Tmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes